View in EDS HTML Full Text PDF Full Text

A CD40-targeting peptide, OPT501, modulates inflammation in canine diabetes mellitus improving clinical outcomes.

Saved in:
Bibliographic Details
Title: A CD40-targeting peptide, OPT501, modulates inflammation in canine diabetes mellitus improving clinical outcomes.
Authors: Vaitaitis GM; Department of Medicine, The University of Colorado Anschutz Medical Campus, Aurora, CO, United States., Waid DM; Op-T LLC., Aurora, CO, United States., Sharkey C; Montclair Animal Clinic, Denver, CO, United States., Sharkey S; Montclair Animal Clinic, Denver, CO, United States., Webb TL; Department of Clinical Sciences, Colorado State University, Fort Collins, CO, United States., Webb C; Department of Clinical Sciences, Colorado State University, Fort Collins, CO, United States., Wagner DH Jr; Department of Medicine, The University of Colorado Anschutz Medical Campus, Aurora, CO, United States.; Op-T LLC., Aurora, CO, United States.
Source: Frontiers in immunology [Front Immunol] 2026 Feb 24; Vol. 17, pp. 1759373. Date of Electronic Publication: 2026 Feb 24 (Print Publication: 2026).
Publication Type: Journal Article
Journal Info: Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet ISSN: 1664-3224 (Electronic) Linking ISSN: 16643224 NLM ISO Abbreviation: Front Immunol Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 41816348
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: A CD40-targeting peptide, OPT501, modulates inflammation in canine diabetes mellitus improving clinical outcomes.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Vaitaitis+GM%22">Vaitaitis GM</searchLink>; Department of Medicine, The University of Colorado Anschutz Medical Campus, Aurora, CO, United States.<br /><searchLink fieldCode="AU" term="%22Waid+DM%22">Waid DM</searchLink>; Op-T LLC., Aurora, CO, United States.<br /><searchLink fieldCode="AU" term="%22Sharkey+C%22">Sharkey C</searchLink>; Montclair Animal Clinic, Denver, CO, United States.<br /><searchLink fieldCode="AU" term="%22Sharkey+S%22">Sharkey S</searchLink>; Montclair Animal Clinic, Denver, CO, United States.<br /><searchLink fieldCode="AU" term="%22Webb+TL%22">Webb TL</searchLink>; Department of Clinical Sciences, Colorado State University, Fort Collins, CO, United States.<br /><searchLink fieldCode="AU" term="%22Webb+C%22">Webb C</searchLink>; Department of Clinical Sciences, Colorado State University, Fort Collins, CO, United States.<br /><searchLink fieldCode="AU" term="%22Wagner+DH+Jr%22">Wagner DH Jr</searchLink>; Department of Medicine, The University of Colorado Anschutz Medical Campus, Aurora, CO, United States.; Op-T LLC., Aurora, CO, United States.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101560960%22">Frontiers in immunology</searchLink> [Front Immunol] 2026 Feb 24; Vol. 17, pp. 1759373. <i>Date of Electronic Publication: </i>2026 Feb 24 (<i>Print Publication: </i>2026).
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Frontiers+Research+Foundation]%22">Frontiers Research Foundation] </searchLink><i>Country of Publication: </i>Switzerland <i>NLM ID: </i>101560960 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Internet <i>ISSN: </i>1664-3224 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2216643224%22">16643224 </searchLink><i>NLM ISO Abbreviation: </i>Front Immunol <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=41816348
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.3389/fimmu.2026.1759373
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 1759373
    Titles:
      – TitleFull: A CD40-targeting peptide, OPT501, modulates inflammation in canine diabetes mellitus improving clinical outcomes.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Vaitaitis GM
      – PersonEntity:
          Name:
            NameFull: Waid DM
      – PersonEntity:
          Name:
            NameFull: Sharkey C
      – PersonEntity:
          Name:
            NameFull: Sharkey S
      – PersonEntity:
          Name:
            NameFull: Webb TL
      – PersonEntity:
          Name:
            NameFull: Webb C
      – PersonEntity:
          Name:
            NameFull: Wagner DH Jr
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 24
              M: 02
              Text: 2026 Feb 24
              Type: published
              Y: 2026
          Identifiers:
            – Type: issn-electronic
              Value: 1664-3224
          Numbering:
            – Type: volume
              Value: 17
          Titles:
            – TitleFull: Frontiers in immunology
              Type: main
ResultId 1